Where are the fifty -- that's not what the clinical data showed.
Clearly ChatGPT doesn't understand FDA Guidance. The ECA Guidance requires ECA be fully detailed PRIOR to the start of the trial. Just because they found trials that did change their endpoint AFTER the trial started, does not mean that the regulators approved the the drug based on the trial. Artificial intelligence still has it's limitations -- like the person operating it.
Market Data 
Markets 
AI
